Kreisman H, Wolkove N
Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Semin Oncol. 1992 Oct;19(5):508-20.
Pulmonary toxicity is often encountered in patients receiving antineoplastic therapy. It may produce a wide variety of clinicopathologic syndromes. As new agents are introduced and their adverse effects recognized, clinicians should be ever vigilant about the possibility of pulmonary toxicity.
接受抗肿瘤治疗的患者常出现肺部毒性。它可能会产生各种各样的临床病理综合征。随着新药物的引入及其不良反应被认识,临床医生应始终警惕肺部毒性的可能性。